Skip to main content
Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
37.01
-0.07 (-0.19%)
At close: Mar 9, 2026, 4:00 PM EDT
36.27
-0.74 (-2.00%)
After-hours: Mar 9, 2026, 6:35 PM EDT

Cogent Biosciences Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
258
Market Cap
5.96B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Caris Life Sciences 812.03M
Mirum Pharmaceuticals 521.31M
Rhythm Pharmaceuticals 189.76M
Protagonist Therapeutics 46.02M
Kymera Therapeutics 39.21M
Arcellx 22.29M
CG Oncology 4.04M
CRISPR Therapeutics AG 3.51M
Revenue Rankings

COGT News

More News